Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 8% Following Insider Selling
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) dropped 8% on Monday after an insider sold shares in the company. The company traded as low as $24.50 and last traded at $23.9150. Approximately 71,215 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 2,503,471 shares. The stock had […]
15 Jan 03:44 · The Markets Daily